Sibylle Pochon

USPTO Granted Patents = 17 (Patent Applications = 3)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 10.0

ph-index = 8

Forward Citations = 124(Granted Patents)

Location History:

Genève, CH (2010)
Troinex, CH (2007 - 2016)

Company Filing History:

Bracco International Bv

patents

4. 2 out of 142

Bracco Imaging S.p.a.

patents

5. 1 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 2007-2016

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9446155 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy (2016-09-20),

2. 9408926 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy (2016-08-09),

3. 9381258 - Targeting vector-phospholipid conjugates (2016-07-05),

4. 9295737 - Targeting vector-phospholipid conjugates (2016-03-29),

5. 8663603 - Multivalent constructs for therapeutic and diagnostic applications (2014-03-04),

6. 8642010 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy (2014-02-04),

7. 8623822 - KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy (2014-01-07),

8. 8551450 - Targeting vector-phospholipid conjugates (2013-10-08),

9. 8466107 - Fibrin-binding peptides and conjugates thereof (2013-06-18),

10. 8293214 - Targeting and therapeutic compounds and gas-filled microvesicles comprising said compounds (2012-10-23),

11. 8278274 - Fibrin-binding peptides and conjugates thereof (2012-10-02),

12. 7985402 - Targeting vector-phospholipid conjugates (2011-07-26),

13. 7910088 - Multivalent constructs for therapeutic and diagnostic applications (2011-03-22),

14. 7854919 - Multivalent constructs for therapeutic and diagnostic applications (2010-12-21),

15. 7846100 - Medical imaging system based on a targeted contrast agent (2010-12-07),

Title: Sibylle Pochon: Innovator in Angiogenesis Research

Introduction

Sibylle Pochon is a prominent inventor based in Troinex, Switzerland. She has made significant contributions to the field of angiogenesis research, holding a total of 17 patents. Her work focuses on the development of innovative polypeptides and their applications in diagnosis and therapy.

Latest Patents

Among her latest patents are the KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy. These inventions provide polypeptides, peptide dimers, and multimeric complexes that include at least one binding moiety for the KDR or VEGF/KDR complex. These innovations are particularly useful in treating, detecting, isolating, or localizing angiogenesis. The synthetic, isolated polypeptides are capable of binding to the KDR or VEGF/KDR complex with high affinity, which is crucial for their effectiveness. Additionally, the patents disclose methods for monitoring and evaluating the therapeutic effectiveness of treatment protocols for diseases associated with angiogenesis or endothelial cell hyperproliferation, such as cancer.

Career Highlights

Sibylle Pochon has worked with notable companies in the biotechnology sector, including Bracco Suisse SA and Dyax Corporation. Her experience in these organizations has contributed to her expertise in the development of therapeutic agents.

Collaborations

Some of her notable coworkers include Philippe Bussat and Rolf E. Swenson. Their collaborative efforts have further advanced the research and applications of her inventions.

Conclusion

Sibylle Pochon is a trailblazer in the field of angiogenesis research, with a strong portfolio of patents that reflect her innovative spirit and dedication to improving therapeutic outcomes. Her contributions continue to impact the medical field significantly.

This text is generated by artificial intelligence and may not be accurate.